XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 9,671 $ 536
Trade receivables - third party and affiliates 1,120 1,161
Non-trade receivables, net 492 506
Inventories 1,723 1,524
Other assets 186 80
Total current assets 13,192 3,807
Investments in affiliates 954 823
Property, plant and equipment (net of accumulated depreciation - 2022: $3,475; 2021: $3,484) 4,089 4,193
Operating Lease, Right-of-Use Asset 246 236
Deferred income taxes 222 248
Other assets 695 521
Goodwill 1,294 [1] 1,412
Intangible assets, net 645 735
Total assets 21,337 11,975
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 977 791
Trade payables - third party and affiliates 1,128 1,160
Other liabilities 555 473
Income taxes payable 128 81
Total current liabilities 2,788 2,505
Long-term debt, net of unamortized deferred financing costs 11,360 3,176
Deferred income taxes 640 555
Uncertain tax positions 314 280
Benefit obligations 489 558
Operating lease liabilities 205 200
Other liabilities 247 164
Commitments and Contingencies
Stockholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2022 and 2021: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2022: 170,090,785 issued and 108,386,739 outstanding; 2021: 169,760,024 issued and 108,023,735 outstanding) 0 0
Treasury stock, at cost (2022: 61,704,046 shares; 2021: 61,736,289 shares) (5,492) (5,492)
Additional paid-in capital 356 333
Retained earnings 10,584 9,677
Accumulated other comprehensive income (loss), net (498) (329)
Total Celanese Corporation stockholders' equity 4,950 4,189
Noncontrolling interests 344 348
Total equity 5,294 4,537
Total liabilities and equity $ 21,337 $ 11,975
[1] There were no accumulated impairment losses as of September 30, 2022.